<SEC-DOCUMENT>0002050492-25-000001.txt : 20250514
<SEC-HEADER>0002050492-25-000001.hdr.sgml : 20250514
<ACCEPTANCE-DATETIME>20250514092643
ACCESSION NUMBER:		0002050492-25-000001
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250514
DATE AS OF CHANGE:		20250514

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elicio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001601485
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				113430072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93548
		FILM NUMBER:		25943058

	BUSINESS ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(857) 209-0050

	MAIL ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Angion Biomedica Corp.
		DATE OF NAME CHANGE:	20140228

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actyus Private Equity SGIIC, S.A.
		CENTRAL INDEX KEY:			0002050492
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			U3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		CALLE SERRANO 37
		CITY:			MADRID
		STATE:			U3
		ZIP:			28001
		BUSINESS PHONE:		34917453400

	MAIL ADDRESS:	
		STREET 1:		CALLE SERRANO 37
		CITY:			MADRID
		STATE:			U3
		ZIP:			28001
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0000950170-25-002866</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002050492</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001601485</issuerCik>
        <issuerName>Elicio Therapeutics, Inc.</issuerName>
        <issuerCusip>28657F103</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>451 D STREET, 5TH FLOOR</com:street1>
          <com:street2>451 D STREET, 5TH FLOOR</com:street2>
          <com:city>BOSTON</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02210</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Actyus Private Equity SGIIC, S.A.</reportingPersonName>
      <citizenshipOrOrganization>U3</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>856382.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>856382.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>856382.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.4</classPercent>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Elicio Therapeutics, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>451 D STREET, 5TH FLOOR, 451 D STREET, 5TH FLOOR, BOSTON, MASSACHUSETTS, 02210.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Actyus Private Equity SGIIC, S.A., a Sociedad Anonima organized under the laws of Spain (Actyus or the Reporting Person), with respect to the shares of Common Stock (as defined in Item 2(d) below) held by Azahar Private Capital, SCR, S.A. a Sociedad Anonima organized under the laws of Spain (Azahar) and NAVIS VB FUND I, a Fund organized under the laws of Spain (Navis). Actyus is the management company of both entities and acts on behalf of Azahar and Navis investors' respective interests.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Calle Serrano, 37 Madrid 28001 SPAIN</principalBusinessOfficeOrResidenceAddress>
        <citizenship>SPAIN</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 15,996,976 shares of Common Stock outstanding as of May 9, 2025, as reported in the Company's Registration Statement on Form 10Q filed with the Securities and Exchange Commission on Mayr 13, 2025.</amountBeneficiallyOwned>
        <classPercent>5.35</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>856,382</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>856,382</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>See Item 2</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Actyus Private Equity SGIIC, S.A.</reportingPersonName>
      <signatureDetails>
        <signature>Yasmina Armengol Hierro</signature>
        <title>Financial Director</title>
        <date>05/14/2025</date>
      </signatureDetails>
      <signatureDetails>
        <signature>Alessia Carretie Colombo</signature>
        <title>Business Development Director</title>
        <date>05/14/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
